These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7691609)

  • 41. Rapid transformant selection by human complement using HRF20 (CD59) cDNA as a selection marker.
    Takizawa H; Takahashi K; Murakami T; Okada N; Okada H
    Eur J Immunol; 1993 Oct; 23(10):2714-6. PubMed ID: 7691615
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protection of gingival epithelium against complement-mediated damage by strong expression of the membrane attack complex inhibitor protectin (CD59).
    Rautemaa R; Meri S
    J Dent Res; 1996 Jan; 75(1):568-74. PubMed ID: 8655761
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The influence of tumour necrosis factor-alpha, interleukin-1 beta and interferon-gamma on the expression and function of the complement regulatory protein CD59 on the human colonic adenocarcinoma cell line HT29.
    Bjørge L; Jensen TS; Ulvestad E; Vedeler CA; Matre R
    Scand J Immunol; 1995 Apr; 41(4):350-6. PubMed ID: 7534941
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhanced expression of the complement regulatory protein, membrane inhibitor of reactive lysis (CD59), is regulated at the level of transcription.
    Holguin MH; Martin CB; Weis JH; Parker CJ
    Blood; 1993 Aug; 82(3):968-77. PubMed ID: 7687899
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack.
    Spiller OB; Criado-García O; Rodríguez De Córdoba S; Morgan BP
    Clin Exp Immunol; 2000 Aug; 121(2):234-41. PubMed ID: 10931136
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resistance against the membrane attack complex of complement induced in porcine endothelial cells with a Gal alpha(1-3)Gal binding lectin: up-regulation of CD59 expression.
    Dalmasso AP; Benson BA; Johnson JS; Lancto C; Abrahamsen MS
    J Immunol; 2000 Apr; 164(7):3764-73. PubMed ID: 10725736
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Physiologic relevance of the membrane attack complex inhibitory protein CD59 in human seminal plasma: CD59 is present on extracellular organelles (prostasomes), binds cell membranes, and inhibits complement-mediated lysis.
    Rooney IA; Atkinson JP; Krul ES; Schonfeld G; Polakoski K; Saffitz JE; Morgan BP
    J Exp Med; 1993 May; 177(5):1409-20. PubMed ID: 7683035
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Upregulation of human neutrophil CD59, a regulator of the membrane attack complex of complement, following cell activation.
    Gordon DL; Papazaharoudakis H; Sadlon TA; Arellano A; Okada N
    Immunol Cell Biol; 1994 Jun; 72(3):222-9. PubMed ID: 7522216
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Urinary excretion of protectin (CD59), complement SC5b-9 and cytokines in membranous glomerulonephritis.
    Lehto T; Honkanen E; Teppo AM; Meri S
    Kidney Int; 1995 May; 47(5):1403-11. PubMed ID: 7543624
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human protectin (CD59), an 18-20-kD homologous complement restriction factor, does not restrict perforin-mediated lysis.
    Meri S; Morgan BP; Wing M; Jones J; Davies A; Podack E; Lachmann PJ
    J Exp Med; 1990 Jul; 172(1):367-70. PubMed ID: 1694224
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD59 (homologous restriction factor 20), a plasma membrane protein that protects against complement C5b-9 attack, in human atherosclerotic lesions.
    Seifert PS; Roth I; Schmiedt W; Oelert H; Okada N; Okada H; Bhakdi S
    Atherosclerosis; 1992 Oct; 96(2-3):135-45. PubMed ID: 1281630
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exceptional resistance of human H2 glioblastoma cells to complement-mediated killing by expression and utilization of factor H and factor H-like protein 1.
    Junnikkala S; Jokiranta TS; Friese MA; Jarva H; Zipfel PF; Meri S
    J Immunol; 2000 Jun; 164(11):6075-81. PubMed ID: 10820293
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decreased expression of the membrane inhibitor of complement-mediated cytolysis CD59 on T-lymphocytes of HIV-infected patients.
    Weiss L; Okada N; Haeffner-Cavaillon N; Hattori T; Faucher C; Kazatchkine MD; Okada H
    AIDS; 1992 Apr; 6(4):379-85. PubMed ID: 1377473
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional analysis of CD59 using complement-dependent cytotoxicity assay.
    Kolev M
    Methods Mol Biol; 2014; 1100():347-53. PubMed ID: 24218274
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Killing of rat glial cells by complement: deficiency of the rat analogue of CD59 is the cause of oligodendrocyte susceptibility to lysis.
    Piddlesden SJ; Morgan BP
    J Neuroimmunol; 1993; 48(2):169-75. PubMed ID: 7693753
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Upregulating CD59: a new strategy for protection of neurons from complement-mediated degeneration.
    Kolev MV; Tediose T; Sivasankar B; Harris CL; Thome J; Morgan BP; Donev RM
    Pharmacogenomics J; 2010 Feb; 10(1):12-9. PubMed ID: 19884909
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation of protein kinases A and C increase lymphocyte penetration through endothelial monolayers.
    Renkonen R
    FEBS Lett; 1990 Jul; 267(1):89-92. PubMed ID: 2163904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of CD59, a human complement system regulatory protein, in extraembryonic membranes.
    Vanderpuye OA; Labarrere CA; McIntyre JA
    Int Arch Allergy Immunol; 1993; 101(4):376-84. PubMed ID: 7689003
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Isolation and characterization of the complement-inhibiting protein CD59 antigen from platelet membranes.
    Morgan BP
    Biochem J; 1992 Mar; 282 ( Pt 2)(Pt 2):409-13. PubMed ID: 1372164
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activity after site-directed mutagenesis of CD59 on complement-mediated cytolysis.
    Zhu X; Gao M; Ren S; Wang Q; Lin C
    Cell Mol Immunol; 2008 Apr; 5(2):141-6. PubMed ID: 18445344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.